Relmada Therapeutics (RLMD) Share-based Compensation (IS) (2024 - 2026)
Relmada Therapeutics (RLMD) reported Share-based Compensation (IS) of $956,200 for Q1 2026, down 73.2% from $3.57 million a year earlier and down 70.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Relmada Therapeutics' Share-based Compensation (IS) came in at $12.19 million, down 52.1% year-over-year; for FY2025, it came in at $14.81 million, down 50.9% from FY2024.
- By year, Share-based Compensation (IS) came in at $30.18 million in FY2024.
- The Q1 2026 figure ranks as the lowest quarterly Share-based Compensation (IS) in data going back to Q1 2024.
- Year over year, Share-based Compensation (IS) has now declined in each of the last five quarters, with an average decline of 55.1% over the last five quarters.
- Per Business Quant data, the three quarters before Q1 2026 came in at $3.28 million (Q4 2025), $3.61 million (Q3 2025) and $4.35 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Relmada Therapeutics | 473.10 Mn | -85.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 956,200.00 |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 6.73 Mn |
| Sep 30, 2024 | 7.95 Mn |
| Jun 30, 2024 | 7.21 Mn |
| Mar 31, 2024 | 8.30 Mn |
API Access
Relmada Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();